Naomi Waithira Selected Research

Naomi Waithira Research Topics

9	Malaria 10/2023 - 01/2019
6	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2023 - 01/2019
4	Infections 03/2024 - 01/2022
4	Glucosephosphate Dehydrogenase Deficiency 10/2023 - 01/2023
4	Vomiting 01/2023 - 01/2020
3	COVID-19 01/2023 - 01/2020
2	Fever (Fevers) 07/2023 - 01/2019
2	Nausea 01/2023 - 01/2022
2	Abdominal Pain (Pain, Abdominal) 01/2023 - 10/2021
2	Vivax Malaria 01/2023 - 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Anorexia 01/2023
1	Melioidosis 01/2023
1	Zoonoses 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Scrub Typhus (Typhus, Scrub) 01/2023
1	Bradycardia 01/2022
1	Headache (Headaches) 10/2021
1	Hypersensitivity (Allergy) 10/2021
1	Neoplasms (Cancer) 01/2019

6	artemisinin (artemisinine)IBA 01/2022 - 01/2019
5	Primaquine FDA Link 10/2023 - 01/2019
5	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2023 - 01/2020
4	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2023 - 01/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2019
4	Mefloquine (Lariam)FDA LinkGeneric 10/2021 - 01/2019
4	piperaquineIBA 10/2021 - 01/2019
3	Antimalarials (Antimalarial Agents)IBA 01/2023 - 01/2019
3	artenimol (dihydroartemisinin)IBA 01/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2023
2	Amodiaquine (Camoquin)FDA Link 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2020
1	Sickle HemoglobinIBA 10/2023
1	BilirubinIBA 10/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	Doxycycline (Periostat)FDA LinkGeneric 01/2023
1	MCOIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Bacterial DNAIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	arterolaneIBA 10/2021
1	ArtemisininsIBA 01/2019